Austin Grant, Inc. – Trademark Portfolio

Entity Type: 03

Austin Grant, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include JET-AG, BIO-SAVE, and JET-OXIDE. The owner is based in Apopka, FL.

www.jetharvest.com

3799 Brantley Place Circle

Apopka, FL 32703

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Austin Grant, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Austin Grant, Inc. have?

Austin Grant, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.

What trademark classes does Austin Grant, Inc. file in?

Austin Grant, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Austin Grant, Inc.'s most well-known trademarks?

Austin Grant, Inc.'s registered trademark portfolio includes well-known marks such as JET-AG, BIO-SAVE, and JET-OXIDE. These are among 3 currently registered trademarks in the portfolio.

What is Austin Grant, Inc.'s trademark registration success rate?

Austin Grant, Inc. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.